Screener
NeoGenomics NEO Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
| Line item | (unaudited)June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total assets | $1,352,243 | $1,359,830 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities | ||
| Accounts payable | $20,953 | $23,090 |
| Accrued compensation | 56,265 | 47,580 |
| Accrued expenses and other liabilities | 23,045 | 11,975 |
| Current portion of operating lease liabilities | 3,722 | 4,776 |
| Current portion of finance lease liabilities | 1,704 | 28 |
Item 1. Financial Statements (unaudited)
FAQ
- What is NeoGenomics's accounts payable?
- NeoGenomics (NEO) reported accounts payable of $20.95M in Q2 2026.
- How has NeoGenomics's accounts payable changed year-over-year?
- NeoGenomics's accounts payable decreased by 23.8% year-over-year, from $27.49M to $20.95M.
- What is the long-term trend for NeoGenomics's accounts payable?
- Over 5 years (2020 to 2025), NeoGenomics's accounts payable has grown at a -1.5% compound annual growth rate (CAGR), from $24.97M to $23.09M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about NeoGenomics's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude